San Diego's aTyr Pharma Inc. said David King resigned as the chief scientific officer of the company, effective Dec. 31.

The drug developer said King resigned to pursue founding a private biotechnology company.

King will assist in transition activities and remain with aTyr as a scientific consultant into 2019.